ArticleBritish journal of cancer2023

Anticipating changes in the HER2 status of breast tumours with disease progression-towards better treatment decisions in the new era of HER2-low breast cancers.

Anthony Bergeron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.